Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Natera Inc (NTRA)

  • SEC News
  • June 18, 2025, 14:50 UTC
  • 2

New Form 144 - Natera, Inc. Filed: 2025-06-18 AccNo: 0001949846-25-000293 Size: 7 KB

Comment Full text

Bioxytran, Inc. (BIXT)

  • Business News
  • June 18, 2025, 14:50 UTC
  • 0

Bioxytran Secures a Source of GMP Quality Camel Hemoglobin

Market reaction Comment Full text

BETTERLIFE PHARMA INC. (BETRF)

  • Business News
  • June 18, 2025, 14:38 UTC
  • 1

USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent

Market reaction Comment Full text

Alnylam Pharmaceuticals Inc (ALNY)

  • Business News
  • June 18, 2025, 14:06 UTC
  • 1

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Market reaction Comment Full text

Elevai Labs (ELAB)

  • Business News
  • June 18, 2025, 13:52 UTC
  • 1

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Market reaction Comment Full text

Cencora INC (COR)

  • SEC News
  • June 18, 2025, 13:51 UTC
  • 2

New Form 144 - Cencora, Inc. Filed: 2025-06-18 AccNo: 0001959173-25-004190 Size: 6 KB

Comment Full text

Ginkgo Bioworks Holdings Inc. (DNA)

  • SEC News
  • June 18, 2025, 13:42 UTC
  • 2

New Form 144 - Ginkgo Bioworks Holdings, Inc. Filed: 2025-06-18 AccNo: 0001959173-25-004188 Size: 44 KB

Comment Full text

BioRestorative Therapies Inc (BRTX)

  • Business News
  • June 18, 2025, 13:35 UTC
  • 1

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

Market reaction Comment Full text

Orchestra Biomed Holdings Inc (OBIO)

  • Business News
  • June 18, 2025, 13:30 UTC
  • 2

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

Market reaction Comment Full text

Cel-Sci Corporation (CVM)

  • Business News
  • June 18, 2025, 13:29 UTC
  • 2

Notification from CEL SCI CORP

Market reaction Comment Full text

Prenetics Global Ltd (PRE)

  • SEC News
  • June 18, 2025, 13:15 UTC
  • 2

New Form 6-K - Prenetics Global Ltd Filed: 2025-06-18 AccNo: 0001628280-25-032021 Size: 46 KB

Comment Full text

MAIA Biotechnology Inc. (MAIA)

  • Business News
  • June 18, 2025, 13:15 UTC
  • 3

MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies

Market reaction Comment Full text

Prenetics Global Ltd (PRE)

  • SEC News
  • June 18, 2025, 13:12 UTC
  • 2

New Form 6-K - Prenetics Global Ltd Filed: 2025-06-18 AccNo: 0001628280-25-032019 Size: 45 KB

Comment Full text

Immuneering Corporation (IMRX)

  • SEC News
  • June 18, 2025, 13:11 UTC
  • 2

New Form 4 - Immuneering Corp Filed: 2025-06-18 AccNo: 0001790340-25-000079 Size: 4 KB

Comment Full text

Outlook Therapeutics Inc. (OTLK)

  • Business News
  • June 18, 2025, 13:05 UTC
  • 2

Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event

Market reaction Comment Full text
  • Previous
  • 132
  • 133
  • 134
  • 135
  • 136
  • Next

Search

News categories

  • Technical Exchange News(9391)
  • Event(407)
  • SEC News(153877)
  • FDA Approval(8780)
  • Company Report(721)
  • Business News(104930)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin